Brief description not available

Researchers at the University of California, Davis have developed single-chain insulin (SCI) technology, an insulin-based therapeutic approach that may improve treatment for diabetes and cancer by combining insulin, IGF, and integrin signaling properties.

Researchers at the University of California, Davis have developed a noninvasive optical technology that simultaneously measures fetal oxygen saturation and blood flow during labor through advanced interferometric spectroscopy.

Researchers at the University of California, Davis have developed a fan-pattern paper phantom enabling continuous and reconstruction-agnostic evaluation of PET spatial resolution under clinical and AI-based reconstruction conditions.

Researchers at the University of California, Davis have developed a rheologically stabilized composition that enables improved viability and function of therapeutic cells delivered endoscopically for intestinal luminal diseases.

Researchers at the University of California, Davis have developed a treatment method leveraging let-7 microRNA restoration to combat aggressive pediatric diffuse midline gliomas with H3K27M mutations.

A novel hardware-software co-designed adaptive pruning technique that improves both efficiency and accuracy of large deep learning models.

Researchers at the University of California, Davis have developed an engineered Escherichia coli platform for efficiently microbial production of lacto-N-tetraose (LNT), an important human milk oligosaccharide, directly from lactose as the sole carbon source. Through metabolic pathway rewiring, optimized lactose utilization, this technology enables a simple, scalable, and cost-effective fermentation process for industrial LNT production.